P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.

Detalles Bibliográficos
Autores principales: Xavier-Ferrucio, J., Luo, C., Angelini, G., Krishnamurthy, S., Patel, N., Pettiglio, M., Collingsworth, T., Isik, M., Ghodssi, A., Halfond, A., Etchin, J., Keschner, Y., Mundelboim, G., Tavares, P., Cummins, C., Falla, A., Hazelbaker, D., Paik, E., Sanchez, J., Ge, G., Lydeard, J., Lin, M. I., Chakraborty, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431284/
http://dx.doi.org/10.1097/01.HS9.0000848572.60330.2f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431284/
http://dx.doi.org/10.1097/01.HS9.0000848572.60330.2f

Ejemplares similares